← FDA Drug Approvals (Drugs@FDA)

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVENTIA HEALTHCARE LIMITED · Approved 2026-03-25

Drug application

FDA Application #

ANDA217829

Application type

Abbreviated New Drug Application (Generic)

Brand name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Generic name

Sitagliptin, Metformin Hydrochloride

Active ingredients

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

INVENTIA HEALTHCARE LIMITED

First approval

2026-03-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown